top of page

Defending the Endless Frontier [STAT Summit 2026 Review #02]

Oct 20
4 min read

Updated: Oct 20

Report 02. Defending the Endless Frontier

Part I. English Version


1. Event / Date & Time

Event: Defending the Endless Frontier

Conference: STAT Summit 2026

Date & Time: October 14, 2026 | 9:00 AM EDT


2. Participants

Speakers

- Sally Kornbluth — President, Massachusetts Institute of Technology (MIT)

- H. Holden Thorp — Editor-in-Chief, Science Family of Journals; Former Chancellor, University of North Carolina at Chapel Hill

Moderator

- Anil Oza — General Assignment Reporter, STAT


3. Summary

Federal Research Funding: Declining and increasingly uncertain U.S. federal research funding is affecting basic science, graduate education, and the long-term scientific talent pipeline.

Global Scientific Competition: China’s rapidly expanding research investment, scientific output, and ability to attract top researchers are reshaping global competition in science and emerging technologies.

Importance of Basic Research: Sustained support for curiosity-driven basic research, talent development, and public trust in science is essential to maintaining a strong innovation ecosystem and enabling future biomedical breakthroughs.


4. Main Discussion

Federal Research Funding and the Scientific Talent Pipeline

The discussion highlighted that MIT’s federal research funding declined from approximately $650 million in 2024 to $550 million in 2026. Because many graduate students are supported through federal research grants, funding uncertainty contributed to a 20% reduction in MIT graduate admissions, raising concerns about the long-term scientific workforce and research pipeline.

MIT is seeking alternative funding through philanthropy and industry partnerships. However, President Sally Kornbluth emphasized that industry generally focuses on applied research and may not be able to support the long time horizons required for fundamental science.

As an example, she noted that the scientific foundation for the pancreatic cancer therapy discussed in the previous session can be traced back approximately 40 years to basic research on the role of RAS in cancer.


Industry–University Collaboration

Kornbluth described industry collaboration as a complementary mechanism for supporting both research and scientific talent.

She cited GE Vernova’s collaboration with MIT, which supports research as well as student training and internships, and noted that the company is doubling the number of students participating in its internship programs.

Such partnerships can provide universities with additional resources while giving companies access to emerging research and highly trained talent, creating a mutually beneficial model for strengthening the innovation ecosystem.


China’s Expanding Scientific Capacity

Holden Thorp highlighted the rapid growth of Chinese scientific output in both quantity and quality, while submissions from the United States are declining.

In Science Advances, the number of published papers from China and the United States has reached roughly equal levels, and Thorp said their publication trajectories could cross in Science itself within the next four to five years.

The speakers also emphasized China’s growing ability to attract scientific talent. Kornbluth noted that some leading scientists who established careers in the United States are returning to China, attracted by competitive financial packages and access to large pools of highly qualified researchers.

She also pointed to the growing presence of Chinese researchers at major AI and quantum science meetings as evidence of China’s increasing scientific momentum.


The Critical Role of Basic Research in Biomedical Innovation

A central theme of the discussion was the unique role of universities in conducting curiosity-driven basic research that may take decades to generate practical applications.

Kornbluth warned that weakening this research base could create a serious gap in the innovation pipeline five, ten, or more years into the future, since many major biomedical and engineering advances originated from fundamental research without an immediate commercial objective.

Thorp distinguished the complementary roles of academia and industry: pharmaceutical companies are highly capable in areas such as medicinal chemistry, lead optimization, and manufacturing, while many new drug targets and biological models originate in academic basic science.

Cancer immunotherapy was highlighted as a representative example. Its development emerged from approximately 30–40 years of fundamental immunology research aimed at understanding how the immune system works, rather than from research originally designed to develop a cancer therapy.


Public Trust and Engagement in Science

The discussion also addressed declining public confidence in higher education and scientific institutions.

Kornbluth described MIT’s “Curiosity on a Mission” campaign and “MIT for America” initiative as efforts to communicate the societal value of research and expand access to STEM education.

She noted that approximately 50% of U.S. high schools do not offer calculus, illustrating disparities in access to educational pathways that prepare students for advanced STEM fields.

The broader message was that research institutions need to engage communities more directly and demonstrate how science and education contribute to opportunities and societal benefits.


5. Insights

Long-Term R&D Pipeline: Biomedical innovation depends on a sustained pipeline connecting basic research, scientific talent development, translational research, and industrial commercialization rather than on downstream drug development alone.


Implications for South Korea: South Korea could consider maintaining long-term investment in curiosity-driven biomedical research while strengthening university–industry collaboration to build a more resilient pipeline for future therapeutic innovation.


Global Collaboration and Talent: As U.S.–China scientific competition intensifies and global talent flows shift, Korea could strengthen its position by expanding international research partnerships, attracting and retaining top scientific talent, and deepening connections with leading global innovation ecosystems.



Comments


© 2026 KHIDI USA ALL RIGHT RESERVED

bottom of page